JP Stock MarketDetailed Quotes

4883 Modalis Therapeutics

Watchlist
  • 87
  • -4-4.40%
20min DelayMarket Closed Feb 28 15:30 JST
6.32BMarket Cap-1.13P/E (Static)

About Modalis Therapeutics Company

Modalis Therapeutics Corp is a drug development company. It is engaged in research and development of Gene Therapy using core platform technology, non-editing CRISPR technology (CRISPR-GNDM). The company's products in pipeline are MDL-201, MDL-202, MDL-204, MDL-205, MDL-206, MDL-101, and MDL-102.

Company Profile

Symbol4883
Company NameModalis Therapeutics
Founded2016-01-14
MarketTSE Growth
Employees37
Fiscal Year Ends12-31
Address16-5 Nihombashi-Kabuto-cho Chuo-ku
Zip Code103-0023
Phone03-6822-4584
Websitemodalistx.com

Company Executives

  • Name
  • Position
  • Salary
  • Haruhiko Morita
  • Representative Director and President
  • --
  • Toshio Furuta
  • Independent Director
  • --
  • Teruhisa Tashima
  • Independent Director
  • --
  • Miyuki Shimane
  • Independent Director
  • --
  • Joseph McCracken
  • Independent Director
  • --
  • Hideki Takeda
  • Independent Director
  • --
Top JP Stock Gainers
Symbol Price % Chg
Pacific Metals
5541
1943 +25.92%
Smile Holdings
7084
1653 +22.54%
Reyuu Japan
9425
487 +19.66%
Architects Studio Japan
6085
617 +19.34%
Generation Pass
3195
750 +15.38%

See the daily top gainer.